
RNXT Valuation
RenovoRx Inc
- Overview
- Forecast
- Valuation
- Earnings
RNXT Relative Valuation
RNXT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, RNXT is overvalued; if below, it's undervalued.
Historical Valuation
RenovoRx Inc (RNXT) is now in the Fair zone, suggesting that its current forward PS ratio of 30.62 is considered Fairly compared with the five-year average of -3.02. The fair price of RenovoRx Inc (RNXT) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:1.30
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
3.61
P/B
Median3y
148.62
Median5y
113.92
-22.21
FCF Yield
Median3y
-44.31
Median5y
-39.09
Competitors Valuation Multiple
The average P/S ratio for RNXT's competitors is 5.13, providing a benchmark for relative valuation. RenovoRx Inc Corp (RNXT) exhibits a P/S ratio of 30.38, which is 491.84% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch

FPAY
FlexShopper Inc
1.290
USD
-2.27%

CPIX
Cumberland Pharmaceuticals Inc
3.515
USD
+4.61%

SNYR
Synergy CHC Corp
3.790
USD
-4.53%

SJ
Scienjoy Holding Corp
0.870
USD
-2.25%

IRD
Opus Genetics Inc
1.180
USD
-2.48%

ISDR
Issuer Direct Corp
9.650
USD
0.00%

SPHL
Springview Holdings Ltd
0.513
USD
-4.65%

AWRE
Aware Inc
2.330
USD
-7.17%

DIST
Distoken Acquisition Corp
0
USD
+29.64%

LDTC
LeddarTech Holdings Inc.
0
USD
-24.92%
FAQ

Is RenovoRx Inc (RNXT) currently overvalued or undervalued?
RenovoRx Inc (RNXT) is now in the Fair zone, suggesting that its current forward PS ratio of 30.62 is considered Fairly compared with the five-year average of -3.02. The fair price of RenovoRx Inc (RNXT) is between to according to relative valuation methord.

What is RenovoRx Inc (RNXT) fair value?

How does RNXT's valuation metrics compare to the industry average?

What is the current P/B ratio for RenovoRx Inc (RNXT) as of Jul 26 2025?

What is the current FCF Yield for RenovoRx Inc (RNXT) as of Jul 26 2025?

What is the current Forward P/E ratio for RenovoRx Inc (RNXT) as of Jul 26 2025?
